These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23324969)

  • 1. Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection.
    Unnanuntana A; Saleh A; Mensah KA; Kleimeyer JP; Lane JM
    J Bone Joint Surg Am; 2013 Jan; 95(2):e8 1-13. PubMed ID: 23324969
    [No Abstract]   [Full Text] [Related]  

  • 2. More on atypical fractures of the femoral diaphysis.
    Kwek EB; Koh JS; Howe TS
    N Engl J Med; 2008 Jul; 359(3):316-7; author reply 317-8. PubMed ID: 18635442
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.
    Kharazmi M; Hallberg P; Warfvinge G; Michaëlsson K
    Rheumatology (Oxford); 2014 Oct; 53(10):1911-3. PubMed ID: 25099769
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical proximal femoral fractures in patients with paget disease receiving bisphosphonate therapy.
    Kilcoyne A; Heffernan EJ
    AJR Am J Roentgenol; 2011 Jul; 197(1):W196-7. PubMed ID: 21700989
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical femoral fracture.
    Khan AA; Kaiser S
    CMAJ; 2017 Apr; 189(14):E542. PubMed ID: 28396331
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
    Rydholm A
    Acta Orthop; 2012 Aug; 83(4):319-20. PubMed ID: 22900912
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman.
    Gopinath KG; Shibu PK
    Hong Kong Med J; 2015 Jun; 21(3):286.e2-3. PubMed ID: 26045077
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical femur fractures: a complication of prolonged bisphosphonate therapy?
    Girgis CM; Seibel MJ
    Med J Aust; 2010 Aug; 193(4):196-8. PubMed ID: 20712536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: drug-associated atypical femoral fractures (DaAFFs): balancing the facts.
    Pazianas M; Smith R
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2340-2. PubMed ID: 24712575
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical femoral fracture risk in patients treated with bisphosphonates.
    Bauer DC
    Arch Intern Med; 2012 Jun; 172(12):936-7. PubMed ID: 22732750
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
    Einhorn TA; Bogdan Y; Tornetta P
    J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical femoral fractures associated with long-term bisphosphonate use.
    Chatterjee S
    CMAJ; 2013 Oct; 185(14):1248. PubMed ID: 23649415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bisphosphonate-associated atypical fractures of the femur: an update of the current evidence].
    Kharazmi M; Schilcher J; Hallberg P; Michaëlsson K
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31529420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and atypical femoral fractures: a time for reflection.
    Compston JE
    Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
    Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
    Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy.
    Porrino JA; Kohl CA; Taljanovic M; Rogers LF
    AJR Am J Roentgenol; 2010 Apr; 194(4):1061-4. PubMed ID: 20308511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hip pain. Bisphosphonate-related atypical subtrochanteric femoral fracture in patient with Paget disease.
    Webb NR; Jesse MK
    Skeletal Radiol; 2016 Jun; 45(6):825-6, 853-4. PubMed ID: 26768260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].
    Ing Lorenzinit K; Meier R; Suva D; Dayer P; Desmeules J; Peter R
    Rev Med Suisse; 2012 Jun; 8(344):1238-42. PubMed ID: 22730621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
    Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
    Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures].
    Schwarz P
    Ugeskr Laeger; 2012 Jan; 174(1-2):30. PubMed ID: 22233716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.